Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

Ridiculous indeed. Assuming that Lymphoseek sales are 75% as solid as the highest revenue estimates, I do not see how the shorts will spread fear about the company at that point...unless of course, they create "the cure" for cancer and make Lymphoseek (and all other cancer treatments) completely unnecessary. Ha! Their supply of shares to short seemed endless yet again today, even with orders of 30,000+ shares on the BID...That can't last either...

As it is, I may tap into my home equity to add another 20,000 shares of NAVB if the shorts will be so kind to continue the artificial decline in price.